Back to SCYX

KINGDON CAPITAL MANAGEMENT, L.L.C. → SCYX

KINGDON CAPITAL MANAGEMENT, L.L.C. SCYX Position History

SCYNEXIS, Inc. • Healthcare

Quarters held
18
Latest value
$1.2M
Q3 2026
Peak value
$5.1M
First seen
Q2 2022

Dollar value over time

Show data table
PeriodPosition value
Q2 2022$2.4M
Q3 2022$3.1M
Q4 2022$2M
Q1 2023$4.5M
Q2 2023$5.1M
Q3 2023$4.3M
Q4 2023$5M
Q4 2023$5M
Q1 2024$3.3M
Q2 2024$4.5M
Q3 2024$3.3M
Q4 2024$2.7M
Q1 2025$2.1M
Q2 2025$1.5M
Q3 2025$1.7M
Q1 2026$1.8M
Q2 2026$1M
Q3 2026$1.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.2M247.8K——
Q2 2026$1M247.8K——
Q1 2026$1.8M1.98M——
Q3 2025$1.7M2.24M——
Q2 2025$1.5M2.24M——
Q1 2025$2.1M2.24M——
Q4 2024$2.7M2.24M——
Q3 2024$3.3M2.24M——
Q2 2024$4.5M2.24M——
Q1 2024$3.3M2.24M——
Q4 2023$5M2.24M——
Q4 2023$5M2.24M——
Q3 2023$4.3M1.88M——
Q2 2023$5.1M1.73M——
Q1 2023$4.5M1.50M——
Q4 2022$2M1.30M——
Q3 2022$3.1M1.30M——
Q2 2022$2.4M1.30M——

Other funds holding SCYX

Other KINGDON CAPITAL MANAGEMENT, L.L.C. positions

SNDX

SYNDAX PHARMACEUTICALS INC

$58.4M
SNDX

SYNDAX PHARMACEUTICALS INC

$54.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$49.4M
NVDA

NVIDIA CORPORATION

$48M
NVDA

NVIDIA CORPORATION

$46.8M
GRAL

GRAIL INC

$44.8M
SNDX

SYNDAX PHARMACEUTICALS INC

$42.2M
INSM

INSMED INC

$41.9M